Just a moment, the page is loading...

To initiate a Research Proposal or to Ask a Question about studies, please do the following:

  • Login and create an account.
  • Click on the Study ID to view Study Details.
  • If you cannot find the specific study you are looking for, click here to submit an Enquiry
×


1 Result:


Sponsor Studies ↑ Description Ready to Share Created
 
GSK GSK-204471 A multi-centre, open label, single arm, 32-week treatment study in subjects with severe eosinophilic asthma not optimally controlled with current omalizumab treatment who are switched from omalizumab to mepolizumab 100mg subcutaneous (study number 204471- the OSMO study) No 6/28/2019